In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
3 weeks 6 days ago
8 weeks 1 hour ago
9 weeks 12 hours ago
9 weeks 15 hours ago
30 weeks 1 day ago
34 weeks 2 days ago
35 weeks 6 days ago
36 weeks 1 hour ago
48 weeks 2 days ago
1 year 1 week ago